Nektar Therapeutics' IPO

Nektar Therapeutics raised a round of funding on February 21, 2001. Investors include Public.

Nektar Therapeutics, Inc. provides a portfolio of leading drug delivery technologies and expertise to enable pharmaceutical and biotechnology companies to maximize the performance of their drug produc…

Articles about Nektar Therapeutics' IPO: